Blueprint Genetics

Blueprint Genetics is a genetic testing company focused on inherited diseases. With a patient-first mindset, the company delivers high-quality genetic testing to the global clinical community across 14 medical specialties. Founded in 2012 and headquartered in Helsinki, Finland, Blueprint Genetics has grown rapidly to serve customers in over 70 countries, working with more than 4,000 clinicians worldwide.

The company combines state-of-the-art laboratory processes, cutting-edge sequencing technology, and AI-empowered data analysis tools with world-class professionals to bring genetic knowledge to mainstream healthcare. By providing clinicians and their patients with comprehensive and high-quality tools and resources for diagnosis of genetic conditions, Blueprint Genetics enables possibilities for targeted treatment and individualized care for patients. The company offers an extensive portfolio including over 220 panels, whole exome sequencing, approximately 3,900 single genes, and targeted variant analysis across specialties such as cardiology, neurology, ophthalmology, and hereditary cancer. Blueprint Genetics maintains prestigious accreditations including CLIA, CAP, and ISO 15189, ensuring the highest standards of quality and reliability in genetic diagnostics.